MART-1 analogs (INSERM)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug NameMART-1 analogs (INSERM)
Drug Alias Namemelanoma vaccine (INSERM)
ClassificationVaccines > Application > Therapeutic vaccineBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionMelanoma antigen recognized by T-cells 1 modulators
TargetsMelanoma antigen recognized by T-cells 1
Therapy Area/IndicationsMelanoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFrance
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesInserm
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesInserm
Active IndicationsN/A
Inactive IndicationsMelanoma

Other Information

ATC CodeN/A
Related LinksN/A